Megumi Morimoto

574 total citations
18 papers, 366 citations indexed

About

Megumi Morimoto is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Megumi Morimoto has authored 18 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cell Biology. Recurrent topics in Megumi Morimoto's work include Hormonal and reproductive studies (5 papers), Adipose Tissue and Metabolism (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Megumi Morimoto is often cited by papers focused on Hormonal and reproductive studies (5 papers), Adipose Tissue and Metabolism (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Megumi Morimoto collaborates with scholars based in Japan and United States. Megumi Morimoto's co-authors include Takahito Hara, Masuo Yamaoka, Takatsugu Okegawa, Katsuji Aikawa, Satoshi Kitazawa, Ryuichi Tozawa, Kohei Honda, Satoru Nishizawa, Toshiya Tamura and Hideo Araki and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Energy and Buildings.

In The Last Decade

Megumi Morimoto

18 papers receiving 354 citations

Peers

Megumi Morimoto
Lori Rice United States
Michael S. Stahler United States
Dimitar K. Gavrilov United States
David O. Osei-Hwedieh United States
Hui Ren China
Sonja Matt Germany
Ninche Alston United States
Delphine Guillotin United Kingdom
Andrew Brandmaier United States
Lori Rice United States
Megumi Morimoto
Citations per year, relative to Megumi Morimoto Megumi Morimoto (= 1×) peers Lori Rice

Countries citing papers authored by Megumi Morimoto

Since Specialization
Citations

This map shows the geographic impact of Megumi Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megumi Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megumi Morimoto more than expected).

Fields of papers citing papers by Megumi Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megumi Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megumi Morimoto. The network helps show where Megumi Morimoto may publish in the future.

Co-authorship network of co-authors of Megumi Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Megumi Morimoto. A scholar is included among the top collaborators of Megumi Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megumi Morimoto. Megumi Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Morimoto, Megumi, Masuo Yamaoka, & Takahito Hara. (2020). A selective androgen receptor modulator SARM‐2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys. Pharmacology Research & Perspectives. 8(1). e00563–e00563. 12 indexed citations
2.
Hara, Takahito, Akiko Kimura, T. Miyazaki, et al.. (2020). Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor. Biochemistry and Biophysics Reports. 21. 100726–100726. 11 indexed citations
3.
Ishikawa, Yoshinori, Megumi Morimoto, Akio Mizutani, et al.. (2017). Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication. Oncogenesis. 6(9). e377–e377. 26 indexed citations
4.
Aikawa, Katsuji, Koji Ono, Noriyuki Habuka, et al.. (2017). Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate. Bioorganic & Medicinal Chemistry. 25(13). 3330–3349. 36 indexed citations
5.
Okegawa, Takatsugu, Megumi Morimoto, Satoru Nishizawa, et al.. (2017). Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors. EBioMedicine. 19. 31–38. 51 indexed citations
6.
Morimoto, Megumi, Yuichiro Amano, Masahiro Oka, et al.. (2017). Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f. PLoS ONE. 12(12). e0189480–e0189480. 16 indexed citations
7.
Arita, Takeo, Megumi Morimoto, Yukiko Yamamoto, et al.. (2017). Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation. Biochemical and Biophysical Research Communications. 488(4). 648–654. 16 indexed citations
8.
Hitaka, Takenori, Takashi Imada, Masami Yamada, et al.. (2017). Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives. Bioorganic & Medicinal Chemistry Letters. 27(9). 1897–1901. 15 indexed citations
9.
Morimoto, Megumi, Katsuji Aikawa, Takahito Hara, & Masuo Yamaoka. (2017). Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models. Oncology Letters. 14(6). 8066–8071. 27 indexed citations
10.
Sumi, Hiroyuki, Masakazu Inazuka, Megumi Morimoto, et al.. (2016). An inhibitor of apoptosis protein antagonist T-3256336 potentiates the antitumor efficacy of the Nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924). Biochemical and Biophysical Research Communications. 480(3). 380–386. 9 indexed citations
11.
Shinagawa, Naofumi, Noriaki Sukoh, Megumi Morimoto, et al.. (2016). Usefulness of Endobronchial Ultrasonography With a Guide Sheath and Virtual Bronchoscopic Navigation for Ground-Glass Opacity Lesions. The Annals of Thoracic Surgery. 103(2). 470–475. 40 indexed citations
12.
Okegawa, Takatsugu, et al.. (2013). Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene. Oncogenesis. 2(7). e58–e58. 29 indexed citations
13.
Hioki, Takeshi, Megumi Morimoto, Tsuneo Masaki, et al.. (2013). Brain Testosterone Deficiency Leads to Down-Regulation of Mitochondrial Gene Expression in Rat Hippocampus Accompanied by a Decline in Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α Expression. Journal of Molecular Neuroscience. 52(4). 531–537. 27 indexed citations
14.
Sumi, Hiroyuki, Masato Yabuki, Kenichi Iwai, et al.. (2012). Antitumor Activity and Pharmacodynamic Biomarkers of a Novel and Orally Available Small-Molecule Antagonist of Inhibitor of Apoptosis Proteins. Molecular Cancer Therapeutics. 12(2). 230–240. 12 indexed citations
15.
Wang, Suya, et al.. (2008). Evaluating the low exergy of chilled water in a radiant cooling system. Energy and Buildings. 40(10). 1856–1865. 17 indexed citations
16.
Morimoto, Megumi & Tatsuro Irimura. (2001). Fibroblast migratory factor derived from mouse colon carcinoma cells: Potential roles of fibronectin in tumor stroma formation. Journal of Cellular Biochemistry. 80(4). 635–646. 1 indexed citations
17.
Morimoto, Megumi, et al.. (2001). Fibroblast migratory factor derived from mouse colon carcinoma cells: Potential roles of fibronectin in tumor stroma formation. Journal of Cellular Biochemistry. 80(4). 635–646. 6 indexed citations
18.
Adachi, Shiro, Tohru Tsujimura, Tomoko Jippo, et al.. (1995). Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor.. PubMed. 23(1). 58–65. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026